Dr. Fradley is an attending cardiologist/electrophysiologist and Medical Director, Penn Cardio-Oncology Program and Associate Professor of Clinical Medicine at the University of Pennsylvania. He is board certified in Cardiovascular Disease as well as Internal Medicine. He then went on to complete fellowships in both Cardiology and Clinical Cardiac Electrophysiology at Massachusetts General Hospital. Dr. Fradley’s current research interests involve the treatment and prevention of cardiovascular disease in cancer patients and survivors. He has published multiple articles and also served on many committees including the Massachusetts Medical Society Committee on Medical Education and the University of South Florida LCME Faculty Affairs committee. He is also heavily involved in medical education, teaching cardiovascular pathophysiology to second year medical students, and serving as the medical director for the Harvey Simulation course. He completed his undergraduate training, with a major in Molecular Biophysics and Biochemistry, at Yale University, where he graduated cum laude with distinction in major. He received his MD degree at the Johns Hopkins School of Medicine, and then remained at Johns Hopkins, completing his residency in Internal Medicine through the Osler Medical Residency Program.Dr. Fradley is an attending cardiologist/electrophysiologist and an Assistant Professor of Medicine at the University of South Florida, Morsani College of Medicine. He serves as the director of the joint USF-Moffitt Cancer Center Cardio-Oncology Program. He is board certified in Cardiovascular Disease, clinical cardiac electrophysiology, as well as Internal Medicine.He completed his undergraduate training, with a major in Molecular Biophysics and Biochemistry, at Yale University, where he graduated cum laude with distinction in major. He received his MD degree at the Johns Hopkins School of Medicine, and then remained at Johns Hopkins, completing his residency in Internal Medicine through the Osler Medical Residency Program.He then went on to complete fellowships in both Cardiology and Clinical Cardiac Electrophysiology at Massachusetts General Hospital. Dr. Fradley’s current research interests involve the treatment and prevention of cardiovascular disease in cancer patients and survivors. He has published multiple articles and also served on many committees including the Massachusetts Medical Society Committee on Medical Education and the University of South Florida LCME Faculty Affairs committee. He is also heavily involved in medical education, teaching cardiovascular pathophysiology to second year medical students, and serving as the medical director for the Harvey Simulation course.

Professor Doan Ngo is an academic pharmacist and a fundamental and translational scientist with multiple important contributions in the cardio-oncology and cardio-metabolic field. She is the co-director of the Newcastle Centre of Excellence in Cardio-Oncology research program, Hunter Medical Research Institute, and National Heart Foundation Future Leader Fellow at the University of Newcastle. Together with Professor Aaron Sverdlov, Doan has established the first-in-Australia bench-to-bedside "cardio-oncology" program combining basic and clinical research into cancer therapy-related cardiotoxicity with Calvary Mater Newcastle Hospital-based clinical outpatient service. The program incorporates mechanistic discovery studies looking at mechanisms of cardiotoxicity, drug discovery studies, translational human research, clinical research and clinical inpatient and outpatient service delivery.

Dr Satish Ramkumar is a consultant cardiologist and interim Head of Non-Invasive Imaging at the Victorian Heart Hospital with sub-specialty training in cardio-oncology and multi-modality cardiac imaging. Satish completed his undergraduate medical degree at the University of Melbourne and completed specialist medical training in cardiology at Monash Health, Western Health and Bendigo Health. Satish has completed a Non-Invasive Imaging fellowship at Monash Heart in 2021, obtaining subspecialty training in echocardiography, transoesophageal echocardiography and cardiac CT. This was followed by a fellowship in cardio-oncology and cardiac MRI at Barts NHS Trust and University College Hospital, London in 2022-2023. He is the Director of Physician Education (DPE) at the Victorian Heart Hospital. He is a board-certified cardio-oncologist with the International Society of Cardio-oncology (ICOS) and works in a large clinical cardio-oncology service at the Victorian Heart Hospital, which has been awarded “Gold status” as a Centre of Excellence status with ICOS. He is also on the steering committee of the Australian Cardio-oncology Research Symposium (ACORES). Satish has completed a Masters in Medicine (Clinical Epidemiology) at the University of Sydney in 2017 and completed his PhD in September 2020 at the Baker Heart and Diabetes Institute. His research focused on the use of advanced imaging markers to predict the risk of developing atrial fibrillation. Satish’s clinical and research interests include improving cardiac outcomes in oncology patients and using cardiac imaging markers in the assessment of cardiotoxicity and valvular heart disease.

Dr. Javid Moslehi is a cardiologist who specializes in the cardiovascular health of cancer patients, cancer survivors and patients with immunological or metabolic problems that affect cardiovascular health. He serves as chief of UCSF's cardio-oncology and immunology section. Moslehi's research focuses on how diseases of the cardiovascular system impact cancer patients and survivors. He is also interested in inflammatory heart conditions, such as myocarditis. Moslehi earned his medical degree from the University of Connecticut School of Medicine. He completed a residency in internal medicine at the Johns Hopkins Hospital. At Brigham and Women's Hospital, he completed a fellowship in cardiology and a postdoctoral research fellowship in oncology. His career includes directing cardio-oncology programs at the Dana-Farber Cancer Institute and Vanderbilt University Medical Center. He is the UCSF William Grossman Distinguished Professor in Cardiology.

Professor Aaron Sverdlov is a cardiologist and clinician-scientist whose work sits at the intersection of heart failure, cancer care and cardiovascular risk. He is Professor in Cardiology and Director of Heart Failure at the University of Newcastle and Hunter Medical Research Institute, Senior Cardiologist with Hunter New England Local Health District, Clinical Lead for Heart Failure and Cardio-Oncology, and Co-Director of the Newcastle Centre of Excellence in Cardio-Oncology. His work is focused on helping patients receive the best possible cancer care while minimising cardiovascular risk. He co-established and co-leads Australia’s first bench-to-bedside cardio-oncology program accredited as an International Cardio-Oncology Society Centre of Excellence. Alongside this, his heart failure work focuses on improving outcomes through better, more accessible models of care, particularly for patients in regional and rural communities. His work spans laboratory science, translational research, clinical trials and service redesign, with a strong practical focus on earlier detection of cardiovascular risk, prevention of treatment-related heart disease, and better long-term care for patients after cancer therapy. A former Heart Foundation Future Leader Fellow and NHMRC CJ Martin Fellow, he has published more than 140 papers, attracted over $20 million in competitive funding, contributed to national and international guidelines, and developed multidisciplinary models of care.